Exploring the specific mechanisms of SWELL1 in these pathological processes can help elucidate the intrinsic relationship between metabolic abnormalities and cancer development, providing new ideas and strategies for metabolic tumor therapy. This evidence concerns the gene LRRC8A and cancer.